Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8+ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice. - Chen, Y; Xie, Y; Chan, T; Sami, A; Ahmed, S; Liu, Q; Xiang, J (Cancer Gene Therapy, 2011)